Relation between acute and long-term cognitive decline after surgery: Influence of metabolic syndrome

Brain, Behavior, and Immunity

Volumn 50, Issue , 2015, Pages 203-208

  Gambus P L ^a,b,c   Troconiz I F ^d   Feng, X ^a   Gimenez Mila M ^b   Mellado, R ^b   Degos, V ^a,e   Vacas, S ^a   Maze, M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HOSPITAL CLÍNIC   (Spain)

^c INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^d UNIVERSITY OF NAVARRA   (Spain)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Acute; Cognitive decline; Learning; Long term; Memory; Metabolic syndrome; Postsurgical

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEAR CONDITIONING TEST; LEARNING; MATHEMATICAL MODEL; MEMORY; METABOLIC SYNDROME X; MORRIS WATER MAZE TEST; NONHUMAN; ORTHOPEDIC SURGERY; POSTOPERATIVE COGNITIVE DYSFUNCTION; PRIORITY JOURNAL; RAT; TIBIA; ANIMAL; COGNITION DISORDERS; COMPLICATION; CONDITIONED REFLEX; FEAR; HINDLIMB; INJURIES; MAZE TEST; METABOLIC DISORDER; METABOLISM; PHYSIOLOGY; POSTOPERATIVE COMPLICATION; PSYCHOLOGY; SURGERY; TIME FACTOR;

ANIMALS; COGNITION DISORDERS; CONDITIONING, CLASSICAL; FEAR; HINDLIMB; MAZE LEARNING; MEMORY; METABOLIC DISEASES; POSTOPERATIVE COMPLICATIONS; RATS; TIME FACTORS;

EID: 84937922700     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2015.07.005     Document Type: Article

References (22)

1. Beal S.L., Sheiner L.B. NONMEM User's Guides Ellicott City, Maryland, USA 2006, Icon Development Solutions, Ellicott City, Maryland, USA, 2006.
2. Cibelli M., Fidalgo A.R., Terrando N., Ma D., Monaco C., Feldmann M., Takata M., Lever I.J., Nanchahal J., Fanselow M.S., Maze M. Role of interleukin-1beta in postoperative cognitive dysfunction. Ann. Neurol. 2010, 68:360-368.
3. Degos V., Vacas S., Han Z., van R.N., Gressens P., Su H., Young W.L., Maze M. Depletion of bone marrow-derived macrophages perturbs the innate immune response to surgery and reduces postoperative memory dysfunction. Anesthesiology 2013, 118:527-536.
4. Feng X., Degos V., Koch L.G., Britton S.L., Zhu Y., Vacas S., Terrando N., Nelson J., Su X., Maze M. Surgery results in exaggerated and persistent cognitive decline in a rat model of the metabolic syndrome. Anesthesiology 2013, 118:1098-1105.
5. Feng X., Zhu Y., Koliwad S.K., Koch L.G., Britton S.L., Maze M. Persistent postoperative cognitive decline is associated with dysregulation of macrophage activation in the white adipose tissue in a rat model of metabolic syndrome 2013, American Society of Anesthesiologists, San Francisco, California.
6. Fidalgo A.R., Cibelli M., White J.P., Nagy I., Noormohamed F., Benzonana L., Maze M., Ma D. Peripheral orthopaedic surgery down-regulates hippocampal brain-derived neurotrophic factor and impairs remote memory in mouse. Neuroscience 2011, 190:194-199.
7. Gambus P.L., Troconiz I.F. Pharmacokinetic-pharmacodynamic modelling in anaesthesia. Br. J. Clin. Pharmacol. 2015, 79:72-84.
8. Koch L.G., Britton S.L. Artificial selection for intrinsic aerobic endurance running capacity in rats. Physiol. Genomics 2001, 5:45-52.
9. Monk T.G., Weldon B.C., Garvan C.W., Dede D.E., van der Aa M.T., Heilman K.M., Gravenstein J.S. Predictors of cognitive dysfunction after major noncardiac surgery. Anesthesiology 2008, 108:18-30.
10. Mould D.R., Upton R.N. Basic concepts in population modeling, simulation, and model-based drug development. CPT. Pharmacometric. Syst. Pharmacol. 2012, 1:e6.
11. Owen J.L., Fiedler-Kelly J. Introduction to Population Pharmacokinetic/Pharmacodynamic Analysis with Nonlinear Mixed Effects Models 2014, Wiley, Hoboken, New Jersey.
12. Pandharipande P.P., Girard T.D., Jackson J.C., Morandi A., Thompson J.L., Pun B.T., Brummel N.E., Hughes C.G., Vasilevskis E.E., Shintani A.K., Moons K.G., Geevarghese S.K., Canonico A., Hopkins R.O., Bernard G.R., Dittus R.S., Ely E.W. Long-term cognitive impairment after critical illness. N. Engl. J. Med. 2013, 369:1306-1316.
13. Pinheiro J.C., Bates D.M. Mixed-Effects Models in S and S-Plus 2000, Springer, New York.
14. Sheiner L.B. A new approach to the analysis of analgesic drug trials, illustrated with bromfenac data. Clin. Pharmacol. Ther. 1994, 56:309-322.
15. Shih J., May L.D., Gonzalez H.E., Lee E.W., Alvi R.S., Sall J.W., Rau V., Bickler P.E., Lalchandani G.R., Yusupova M., Woodward E., Kang H., Wilk A.J., Carlston C.M., Mendoza M.V., Guggenheim J.N., Schaefer M., Rowe A.M., Stratmann G. Delayed environmental enrichment reverses sevoflurane-induced memory impairment in rats. Anesthesiology 2012, 116:586-602.
16. Soto E., Staab A., Doege C., Freiwald M., Munzert G., Troconiz I.F. Comparison of different semi-mechanistic models for chemotherapy-related neutropenia: application to BI 2536 a Plk-1 inhibitor. Cancer Chemother. Pharmacol. 2011, 68:1517-1527.
17. Su X., Feng X., Terrando N., Yan Y., Chawla A., Koch L.G., Britton S.L., Matthay M.A., Maze M. Dysfunction of inflammation-resolving pathways is associated with exaggerated postoperative cognitive decline in a rat model of the metabolic syndrome. Mol. Med. 2012, 18:1481-1490.
18. Su X., Feng X., Terrando N., Yan Y., Chawla A., Koch L.G., Britton S.L., Matthay M.A., Maze M. Dysfunction of inflammation-resolving pathways is associated with exaggerated postoperative cognitive decline in a rat model of the metabolic syndrome. Mol. Med. 2013, 18:1481-1490.
19. Terrando N., Monaco C., Ma D., Foxwell B.M., Feldmann M., Maze M. Tumor necrosis factor-alpha triggers a cytokine cascade yielding postoperative cognitive decline. Proc. Natl. Acad. Sci. U.S.A 2010, 107:20518-20522.
20. Terrando N., Rei F.A., Vizcaychipi M., Cibelli M., Ma D., Monaco C., Feldmann M., Maze M. The impact of IL-1 modulation on the development of lipopolysaccharide-induced cognitive dysfunction. Crit. Care 2010, 14:R88.
21. Troconiz I.F., Cendros J.M., Soto E., Prunonosa J., Perez-Mayoral A., Peraire C., Principe P., Delavault P., Cvitkovic F., Lesimple T., Obach R. Population pharmacokinetic/pharmacodynamic modeling of drug-induced adverse effects of a novel homocamptothecin analog, elomotecan (BN80927), in a Phase I dose finding study in patients with advanced solid tumors. Cancer Chemother. Pharmacol. 2012, 70:239-250.
22. Vacas S., Degos V., Tracey K.J., Maze M. High-mobility group box 1 protein initiates postoperative cognitive decline by engaging bone marrow-derived macrophages. Anesthesiology 2013.